Manas AI

Manas AI is an AI-enabled drug discovery startup co-founded in January 2025 by Reid Hoffman (LinkedIn co-founder and prominent AI investor) and Siddhartha Mukherjee (Pulitzer Prize-winning oncologist and author of "The Emperor of All Maladies"). The company raised approximately $25 million in initial funding.

Manas AI uses artificial intelligence to accelerate the drug discovery process, applying machine learning to identify promising drug candidates, predict molecular interactions, and optimize therapeutic compounds. The company brings together Hoffman's technology and AI expertise with Mukherjee's deep understanding of cancer biology and clinical medicine — a combination designed to bridge the gap between AI capability and pharmaceutical domain knowledge.

As an early-stage company, Manas AI represents the growing trend of prominent tech investors and world-class scientists jointly founding AI-driven biotech ventures. The company joins a wave of AI drug discovery startups (including Isomorphic Labs, Recursion, and Insilico Medicine) that are betting AI can dramatically reduce the time and cost of bringing new therapeutics to patients.